Overall survival results of ICON6: A trial of chemotherapy and cediranib in relapsed ovarian cancer

Jonathan A. Ledermann, Andrew C. Embleton, Timothy Perren, Gordon C. Jayson, Gordon J. S. Rustin, Stanley B. Kaye, Hal W. Hirte, Amit M. Oza, Michelle Margaret Vaughan, Michael Friedlander, Antonio Gonzalez Martin, Elizabeth Clark, Babasola O Popoola, Laura Farrelly, Ann Marie Swart, Adrian Cook, Richard S. Kaplan, Mahesh KB Parmar, ICON6 Collaborators

University College London Cancer Institute, London, United Kingdom
MRC Clinical Trials Unit at UCL, London, United Kingdom
St James University Hospital, Leeds, United Kingdom
CRUK Manchester Institute, Manchester, United Kingdom
Mount Vernon Hospital, Northwood, United Kingdom
The Institue of Cancer Research, The Royal Marsden NHS Foundation Trust, London, United Kingdom
Juravinski Cancer Centre, Hamilton, ON, Canada
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
Christchurch Hospital, Christchurch, New Zealand
The Prince of Wales Hospital, Randwick, Australia
GEICO and MD Anderson Cancer Center Madrid, Madrid, Spain
Comprehensive Clinical Trials Unit at UCL, London, United Kingdom
CRUK and UCL Cancer Trials Centre, London, United Kingdom
Norwich Clinical Trials Unit, Norwich, United Kingdom